You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Pharmacogenomic technologies: a necessary "luxury" for better global public health?
|
|---|---|
| Published in |
Globalization and Health, August 2011
|
| DOI | 10.1186/1744-8603-7-30 |
| Pubmed ID | |
| Authors |
Catherine Olivier, Bryn Williams-Jones |
| Abstract |
Pharmacogenomic technologies aim to redirect drug development to increase safety and efficacy of individual care. There is much hope that their implementation in the drug development process will help respond to population health needs, particularly in developing countries. However, there is also fear that novel pharmacogenomic drugs will remain too costly, be designed for the needs of the wealthy nations, and so constitute an unnecessary "luxury" for most populations. In this paper, we analyse the promise that pharmacogenomic technologies hold for improving global public health and identify strategies and challenges associated with their implementation. |
Mendeley readers
The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Mexico | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 83 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 13 | 15% |
| Student > Master | 12 | 14% |
| Student > Ph. D. Student | 10 | 12% |
| Researcher | 8 | 9% |
| Professor | 5 | 6% |
| Other | 14 | 16% |
| Unknown | 24 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 22% |
| Nursing and Health Professions | 7 | 8% |
| Social Sciences | 6 | 7% |
| Engineering | 4 | 5% |
| Agricultural and Biological Sciences | 4 | 5% |
| Other | 22 | 26% |
| Unknown | 24 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2011.
All research outputs
#22,756,649
of 25,371,288 outputs
Outputs from Globalization and Health
#1,221
of 1,226 outputs
Outputs of similar age
#124,016
of 134,580 outputs
Outputs of similar age from Globalization and Health
#14
of 14 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,226 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 134,580 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.